glp-1 drugs and anesthesia medications safe to continue before surgery in patients with diabetes obesity GLP-1 medications safe to continue

Medicaid coverage for GLP-1 drugs varies significantly by state and plan, with most programs requiring prior authorization and medical documentation of BMI, comorbidities, or failed weight loss attempts

Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide and tirzepatide, have emerged as transformative agents for type 2 diabetes and obesity through their potent effects on weight reduction, insulin sensitivity, and cardiovascular outcomes

Not intended for use if you are pregnant or nursing

Natural GLP-1 Support: This advanced formula is crafted to naturally support and produce a key factor in appetite regulation and metabolic balance

Gastric ultrasound identifies increased residual gastric contents in patients on GLP-1 receptor agonists, showing that shorter drug withholding and fasting times are linked to higher aspiration risk before anesthesia.